NEON trial in Parkinson’s patients: Dose escalation completed – Amendment approved to continue treatment for patients …
Read more
CLINAM Award 2022 for special achievements in nanomedicine for Stéfan Halbherr and InnoMedica The Scientific Committee of …
First Parkinson’s patients in the NEON study treated On December 14, 2021, the clinical trial (NEON …
InnoMedica has reached an important milestone with the submission of the first Clinical Trial Application to …
Both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) approved InnoMedica’s …
InnoMedica is close to submission of the marketing authorization application for its chemotherapy and plans to …
In 2020, the InnoMedica team, now counting 39 employees, was able to reach important milestones. The …
As a result of the successful financing round of CHF 10 million in April 2020, the …
The corona pandemic is a major challenge for everyone. In this context, InnoMedica plans to contribute …
The Board of InnoMedica invites all shareholders to attend the Annual General Meeting 2019. The Annual General Meeting …